When Genentech licensed experimental drug vixarelimab from Kiniksa Pharmaceuticals KNSA0.46%increase; green up pointing triangle, its scientists thought they had a future lung medicine in their hands.

Kairos Pharma (KAPA) announced that through its academic partnership with Cedars-Sinai Medical Center, Cedars-Sinai has received $600,000 in ...

In short, VersAI™ is much greener AI. It’s truly remarkable that a pharmaceutical company is at the forefront of developing fundamental new AI technology that outperforms industry titans like Google, ...

ClinFAST represents a significant advancement in our ability to ensure biotech and pharma companies can access the high-quality drug product manufacturing they need—without the typical wait times.

Barclays analyst Gena Wang maintained a Buy rating on Alnylam Pharma (ALNY – Research Report) today and set a price target of $329.00. The company’s shares closed yesterday at $264.89.

Designing custom fonts based on a brand’s logo has become something of a flex for companies like WK Kellogg Co and T.J. Maxx, and it makes sense. Take one of a brand’s best-known assets and ...

The 1/1 licensing model means that Emblème is unique to one brand, making it kind of like the NFT of the typography world.

As regulators and commercial payers tighten the screws on pharma’s profits, companies need to get the ball rolling early to position drugs for a competitive market. Convincing payers and doctors ...

Amid tough biotech industry market conditions last year, investors and Big Pharma companies were more likely to make deals with later-stage biotechs. Local industry leaders say that could change ...

Pharma companies operate in a highly regulated - and risk-averse - environment. Internally, their operations are likely to be hierarchical, process-led, and (often) slow. So, it’s to be expected ...

Pharmaceutical company Haleon will invest $54.2 million to upgrade its research and development facility in Richmond and launch an internship program in partnership with state government and Virginia ...

In 2018, 16 of the top 20 publicly traded pharmaceutical players globally reported year-on-year growth in their revenue, with three companies – Takeda, Celgene (currently under a merger ...